Cirtec Medical Corp., Minneapolis, announces that it has signed a lease on an 85,000 sq. ft. manufacturing facility near its current facility in Brooklyn Park that will focus on active implantable device manufacturing. This follows Cirtec’s recent announcement of plans to build a 30,000 sq. ft. manufacturing facility in the Coyol Free Zone, located in Alajuela, Costa Rica. The addition of these facilities is part of Cirtec’s strategic plan to support current and future partners.
The new state-of-the-art facility will become the company’s Neuromodulation Center of Excellence. It will focus on active implantable device manufacturing and clean room assembly of neuromodulation leads, implantable pulse generators (IPGs), and accessories. In addition, it will allow for expanded engineering competencies in mechanical, process, quality, electrical engineering, software, firmware, and testing.
Other capabilities will include silicone injection molding, plastic injection molding, final packaging, and ethylene oxide sterilization. This facility will expand the company’s presence in Minnesota, and underscores Cirtec’s ongoing commitment and investment in the area’s medical device industry and local job market.
Cirtec CEO Brian Highley commented, “The new site and the addition of our Costa Rica facility are necessary to ensure that we have the capacity to support our customers’ growth over the longer term.”
Construction on the new facility is expected to begin in the first quarter of 2020, with completion targeted in the second half of the year. The existing Brooklyn Park facility will become an all-metals component and sub-assemblies facility, focusing on nitinol processing, Swiss machining, milling, stamping, coil winding, and laser cutting and welding.
